ENTRY       D09944                      Drug
NAME        Ozoralizumab (USAN);
            Ozoralizumab (genetical recombination) (JAN);
            Nanozora (TN)
FORMULA     C1682H2608N472O538S12
EXACT_MASS  38410.7875
MOL_WEIGHT  38434.3245
CLASS       Anti-inflammatory
             DG01985  Disease modifying anti-rheumatic drug (DMARD)
              DG01936  TNF inhibitor
REMARK      Therapeutic category: 3999
            Product: D09944<JP>
EFFICACY    Anti-inflammatory, Anti-TNF-alpha antibody
  TYPE      Monoclonal antibody, nanobody
COMMENT     Treatment of inflammation
TARGET      TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]
  PATHWAY   hsa04010(7124)  MAPK signaling pathway
            hsa04060(7124)  Cytokine-cytokine receptor interaction
            hsa04350(7124)  TGF-beta signaling pathway
INTERACTION  
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D09944  Ozoralizumab (USAN); Ozoralizumab (genetical recombination) (JAN)
            Drug groups [BR:br08330]
             Anti-inflammatory
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               DG01936  TNF inhibitor
                D09944  Ozoralizumab
            Drug classes [BR:br08332]
             Immunological agent
              DG01936  TNF inhibitor
               D09944  Ozoralizumab
             Antirheumatic agent
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               D09944  Ozoralizumab
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Tumor necrosis factors
                TNF (TNFA, TNFSF2)
                 D09944  Ozoralizumab (USAN) &lt;JP&gt;
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D09944
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D09944
DBLINKS     CAS: 1167985-17-2
            PubChem: 124490626
///
